Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs NuuVim

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NuuVim head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 330 · Grade C

NuuVim

Visit NuuVim Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make NuuVim a bad call — it's best for people comparing injection and sublingual options who can budget for three-month billing and the published renewal rate. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
61
Transparency
90
72
Access Breadth
93
62
Clinical Oversight
92
54
Track Record
88
53
CoreAge RxBrief Score 94 · 62NuuVim

Price, coverage & the tracker

CoreAge RxNuuVim
Brief Score94/100 (A)62/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$237 first 3 months

New GLP-1 users; standard $399 per three-month plan.

Injection or sublingual liquid; selected prescription quote unknown.

Full price details

Compounded semaglutide injection or sublingual liquid offered; complete selected-plan quote unknown; $237 first 3 months for new GLP-1 users, then $399 per 3-month standard plan; advertised monthly equivalents $79 then $133

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$399 first 3 months

New GLP-1 users; standard $599 per three-month plan.

Injection or sublingual liquid; selected prescription quote unknown.

Full price details

Compounded tirzepatide injection or sublingual liquid offered; complete selected-plan quote unknown; $399 first 3 months for new GLP-1 users, then $599 per 3-month standard plan; advertised monthly equivalents $133 then $199.67

CoverageUS only; restrictions by state, confirmed at intakeTerms advertise all 50 states plus DC, subject to clinician licensing and medication, formulation and pharmacy restrictions.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

NuuVim: NuuVim offers injectable and oral GLP-1 plans, but its lowest prices require a three-month payment and increase after the introductory period.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.